Kanadevia (TSE:7004) has put its High CO2 Concentration Waste Incineration Technology into the spotlight by launching a world first demonstration at Tokyo’s Shinagawa Incineration Plant that directly targets efficient CO2 capture in Waste to Energy operations.
Over the past year, Kanadevia has seen its share price return move up 7.92% year to date, but decline over shorter windows, including a 30 day share price return down 11.76%. The 3 year total shareholder return of 42.77% points to momentum built over a longer horizon.
Scan for other decarbonization plays with similar momentum shifts by reviewing our hand picked list of solid balance sheet and fundamentals (23 results) alongside Kanadevia's latest move in high CO2 concentration waste incineration.
Kanadevia’s shares trade at ¥1,035 while analyst targets and intrinsic estimates sit meaningfully higher. The question is where fair value really lines up once that spread is unpacked next.
Against the last close of ¥1,035, the most followed narrative points to a fair value of ¥1,300, which implies a sizeable valuation gap for Kanadevia once its long term projects are factored in using a discount rate of 8.07%.
The analysts have a consensus price target of ¥1300.0 for Kanadevia based on their expectations of its future earnings growth, profit margins and other risk factors.
In order for you to agree with the analysts, you would need to believe that by 2029, revenues will be ¥752.2 billion, earnings will come to ¥29.5 billion, and it would be trading on a PE ratio of 9.4x, assuming you use a discount rate of 8.1%.
See why 1 investors see Kanadevia as 20% undervalued.
Result: Fair Value of ¥1,300 (UNDERVALUED)
Still, the Oman green hydrogen story hinges on complex project execution. Any repeat of past cost overruns or compliance issues could quickly puncture this Kanadevia narrative.
Find out about the key risks to this Kanadevia narrative.
Mixed signals in the Kanadevia story can be useful if you put them in context quickly and compare them with your own expectations. To see the balance of concerns and potential upside in one place, review the 3 key rewards and 3 important warning signs
If you stop with Kanadevia, you only see one angle. Use the Simply Wall St screener to line up fresh ideas that fit your own rules.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com